These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 6897544)

  • 21. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of molsidomine in patients with acute myocardial infarction.
    Reifart N; Neidl K; Kaltenbach M; Bussmann WD
    Am Heart J; 1985 Mar; 109(3 Pt 2):708-12. PubMed ID: 3919550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activity of molsidomine in experimental models of ischemic cardiac disease.
    Nitz RE; Martorana PA
    Am Heart J; 1985 Mar; 109(3 Pt 2):631-6. PubMed ID: 3919549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)].
    Meyer J; Sprauer R; Krebs W; Erbel R; Schweizer P; Effert S
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1210-6. PubMed ID: 6893579
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemodynamic effects of molsidomine in chronic congestive heart failure].
    Humar F; Maras P; Musitelli G; Camerini F
    G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of molsidomine on the coronary circulation in anesthetized dogs.
    Fiedler VB; Nitz RE
    Basic Res Cardiol; 1982; 77(3):270-7. PubMed ID: 6896818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of nitroglycerin and molsidomine. Effects on the integrated systemic venous bed and the arterial pressure in dogs.
    Grund E; Müller-Ruchholtz ER; Lapp ER; Lösch HM; Lochner W
    Arzneimittelforschung; 1978; 28(9):1624-8. PubMed ID: 113018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of an NO-releasing pirsidomine derivative on coronary conductance during long-term administration.
    Bassenge E; Zanzinger J
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S22-6. PubMed ID: 7504764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of molsidomine on coronary collateral blood flow in acute myocardial ischemia.
    Gross GJ; Gharaibeh M
    Eur J Pharmacol; 1980 Oct; 67(1):111-4. PubMed ID: 6893436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of vasodilation by molsidomine.
    Kukovetz WR; Holzmann S
    Am Heart J; 1985 Mar; 109(3 Pt 2):637-40. PubMed ID: 2983523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic and coronary effects of molsidomine in patients with stable coronary insufficiency in the basal state, during an atrial stimulation test and a cold test].
    Gourgon R; Neukirch F; Zygelman M; Michel PL; Mérillon JP; Pansard Y; Squara P; Laurent S; Dahan M; Juliard JM
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):529-34. PubMed ID: 6689395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].
    Schulz W; Wendt T; Scherer D; Kober G
    Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cellular mechanism of action of molsidomine. Bioinduction of prostacyclin].
    Poincelot B; Russo-Marie F
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):535-7. PubMed ID: 6421223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molsidomine in the treatment of acute heart failure.
    Drajer S; Vazquez A; Cercós H; Torres H; Cohn JL; Romero N; Faerman G; Soifer S; Nijensohn CM
    Am Heart J; 1985 Mar; 109(3 Pt 2):712-5. PubMed ID: 3838409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].
    Bussmann WD; Neidl K; Kaltenbach M
    Klin Wochenschr; 1982 Jan; 60(2):77-85. PubMed ID: 6896077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.